Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cell Therapeutics: Empty Promises
TheStreet.com
Tuesday, October 19, 2010 - 11:36am
tags:
Cell Therapeutics, lymphoma, pixantrone
Forest Laboratories 2Q profit grows 53 percent
Yahoo/AP
Tuesday, October 19, 2010 - 11:23am
tags:
earnings, Forest Labs
ShangPharma's IPO: Priced About Right for the Short Term
Seeking Alpha
Tuesday, October 19, 2010 - 11:09am
tags:
ShangPharma, IPOs, China
Biosimilar threat tarnishes Novo's star status
Reuters
Tuesday, October 19, 2010 - 11:07am
tags:
Novo Nordisk, insulin, biosimilars, Biocon, Pfizer
Mother sues Abbott over beetles in Similac formula
Chicago Breaking Business, IL
Tuesday, October 19, 2010 - 10:42am
tags:
Abbott Laboratories, Similac, lawsuits, infant formula, recalls
Lawyers Get a Step Closer to Skeletons in Pfizer’s Vaccine Closet
BNET Pharma
Tuesday, October 19, 2010 - 10:42am
tags:
Pfizer, vaccines, Trovan, meningitis, Nigeria
Amgen's Anemia Drug Aranesp Is Safe Before Kidney Dialysis, FDA Panel Says
Bloomberg
Tuesday, October 19, 2010 - 10:34am
tags:
Amgen, anemia, Aranesp, dialysis
Mylan says court won't block other Paxil generics
Yahoo/AP
Tuesday, October 19, 2010 - 9:19am
tags:
Paxil, Mylan, antidepressants, generics, Apotex, GSK
J&J's 3Q profit rises slightly, despite lower sales due to repeated consumer product recalls
Yahoo/AP
Tuesday, October 19, 2010 - 9:18am
tags:
earnings, JNJ, recalls
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Bloomberg
Tuesday, October 19, 2010 - 9:17am
tags:
Pfizer, Biocon, insulin, biosimilars
J&J again recalls Tylenol for moldy smell
Yahoo/AP
Monday, October 18, 2010 - 10:23pm
tags:
JNJ, recalls, Tylenol
How The Placebo Effect Will Help Allergan Sell Botox
Forbes
Monday, October 18, 2010 - 10:23pm
tags:
migraines, Botox, Allergan
Earnings Preview: Johnson & Johnson
Seeking Alpha
Monday, October 18, 2010 - 4:34pm
tags:
JNJ, earnings
Forest Labs: Earnings Preview
Yahoo/Zacks.com
Monday, October 18, 2010 - 3:10pm
tags:
earnings, Forest Labs, Cypress Bioscience
Somaxon Pharmaceuticals Announces Paragraph IV ANDA Filing for Silenor
Yahoo
Monday, October 18, 2010 - 3:09pm
tags:
Somaxon, ANDAs, Silenor
Brother, Can You Spare A Prescription?
Pharmalot
Monday, October 18, 2010 - 3:07pm
tags:
economy, drug data, prescription data
Roche seeks OK for juvenile Actemra use
Fierce Pharma
Monday, October 18, 2010 - 1:42pm
tags:
Roche, pediatrics, Actemra, juvenile arthritis
Lexicon Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Monday, October 18, 2010 - 1:38pm
tags:
Lexicon Pharmaceuticals
Glaxo Turns its Eye to ‘Bubble Boy Disease’ in Rare Disease Push
WSJ Online
Monday, October 18, 2010 - 1:37pm
tags:
GSK, ADA-SCID
Earnings Preview: Abbott Laboratories
Yahoo/AP
Monday, October 18, 2010 - 1:35pm
tags:
earnings, Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.